Your browser doesn't support javascript.
loading
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort.
Bigaut, Kévin; Fabacher, Thibaut; Kremer, Laurent; Ongagna, Jean-Claude; Kwiatkowski, Arnaud; Sellal, François; Ferriby, Didier; Courtois, Sylvie; Vermersch, Patrick; Collongues, Nicolas; Zéphir, Hélène; De Seze, Jérôme; Outteryck, Olivier.
Afiliação
  • Bigaut K; Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France/Clinical Investigation Center, INSERM U1434, Strasbourg, France/Biopathology of Myelin, Neuroprotection and Therapeutic Strategies, INSERM U1119, Strasbourg, France.
  • Fabacher T; Groupe méthode en recherche clinique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Kremer L; Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France/Clinical Investigation Center, INSERM U1434, Strasbourg, France/Biopathology of Myelin, Neuroprotection and Therapeutic Strategies, INSERM U1119, Strasbourg, France.
  • Ongagna JC; Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Kwiatkowski A; Department of Neurology, Hôpital Saint Vincent De Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.
  • Sellal F; Department of Neurology, Hôpitaux Civils de Colmar, Colmar, France.
  • Ferriby D; Department of Neurology, Centre Hospitalier de Tourcoing, Tourcoing, France.
  • Courtois S; Department of Neurology, Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse, France.
  • Vermersch P; Department of Neurology, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Collongues N; Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France/Clinical Investigation Center, INSERM U1434, Strasbourg, France/Biopathology of Myelin, Neuroprotection and Therapeutic Strategies, INSERM U1119, Strasbourg, France.
  • Zéphir H; Department of Neurology, Centre Hospitalier Universitaire de Lille, Lille, France.
  • De Seze J; Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France/Clinical Investigation Center, INSERM U1434, Strasbourg, France/Biopathology of Myelin, Neuroprotection and Therapeutic Strategies, INSERM U1119, Strasbourg, France.
  • Outteryck O; Department of Neurology, Centre Hospitalier Universitaire de Lille, Lille, France/Department of Neuroradiology, Centre Hospitalier Universitaire de Lille, Lille, France.
Mult Scler ; 27(5): 729-741, 2021 04.
Article em En | MEDLINE | ID: mdl-32643521
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Ano de publicação: 2021 Tipo de documento: Article